Business Wire

TRAXENS

28.5.2019 09:02:10 CEST | Business Wire | Press release

Share
Traxens Successfully Deploys Connected Freight Wagons in Collaboration With CFL Multimodal

Traxens, a company providing high-value data and services for the supply chain industry, announces today that its patented cargo tracking IoT system will be used on CFL multimodal’s connected freight wagons throughout the European corridor and the New Silk Road to China.

Traxens and CFL multimodal (CFL) started their co-operation with a pilot project at the end of 2018, when CFL fitted Traxens Box devices on flat wagons travelling between European destinations. As this initial trial was successful, it was extended earlier this year to over 20 wagons delivering cargo to more distant European destinations. In April 2019 Traxens’ rail freight telematics technology was then tested on wagons travelling to China.

As part of it digitalization strategy, CFL aims to streamline train preparation operations through automation, including digital brake testing. Traxens’ Digital Freight Train® solutions can consolidate, secure and accelerate brake safety testing. This testing system can bring a number of benefits:

  • Thirty minutes saved on standard reallocation processes to improve robustness or optimize loading
  • Continuous monitoring of the brake system after departure, with real-time alerts for the train driver to prevent a flat wheel
  • Improved safety and working conditions for shunting and ground operators who perform brake tests
  • Can be used solely by the train driver instead of two agents — reducing operating costs and improving agility and quality of the whole system
  • In the longer term, it will allow the interconnection of operators systems to improve interoperability and international trade, leading to better global efficiency of rail freight

Traxens’ solution provides comprehensive, precise and timely data about cargo by tracking wagons in transit anywhere in the world. Traxens’ technology brings improved efficiency and security, greater transparency and enhanced asset utilization thanks to improved wagons and goods tracking, geolocalisation and mileage monitoring.

The Traxens Box is straightforward to install within a few minutes whether on the customers’ sites, at railway terminals or workshops; it can be adapted to any type of wagon.

“As an outcome of our joint pilot project, we are delighted that CFL multimodal decided to extend its use of our bespoke IoT technology in its rail freight operations to China,” said Florence Delalande, rail business unit director at Traxens. “This shows the potential of our technology for all rail and intermodal freight businesses, as the shipping industry shifts towards a digital future.”

“Traxens’ rail freight solution helps our operations by enabling the monitoring of assets and their surroundings, which significantly improves operational efficiency,” said Marc Valette, innovation director at CFL multimodal. “The technology used by Traxens, enabling the local interconnection of different devices without wiring, opens up new opportunities in train condition and composition monitoring. This is a huge opportunity to improve operations and service effectiveness in rail. It will allow the connection of different elements of the train ecosystem in the future, providing transparent and accurate information, improving the quality of service and information delivered to clients.”

This agreement with CFL Multimodal is the latest development for Traxens in the rail sector. Traxens has already started cooperations with other key players in the industry, such as SNCF (the French national railway company). In cooperation with SNCF Logistics, Traxens developed the Digital Freight Train and its high value-added services for the benefit of the entire railway system, by turning conventional wagons into intelligent wagons in record time. It features geolocation, arrival notifications, consignment transport conditions and status monitoring, digital assistance for wagon management, predictive maintenance and more. Traxens offers a whole range of services for a safer, more modern, eco-friendly and more efficient freight railway system.

This year Traxens has already won several innovation awards for its Digital Freight Train project.

About CFL Multimodal
CFL multimodal is a logistics service provider, covering the entire logistics chain. With 12 companies in six European countries, CFL multimodal and its sister company CFL cargo offer a broad and customised service portfolio: combined and conventional rail freight, wagon maintenance and repairs, customs clearance, as well as forwarding and logistics services. In Luxembourg, the activities of CFL multimodal are organised around the intermodal terminal of Bettembourg-Dudelange on the Eurohub South Logistics Park. Located on the Rail Freight Corridor 2 (North Sea-Mediterranean) and at the crossroads of major transport routes, the terminal is ideally positioned as an international hub for the consolidation of multimodal transport flows across Europe and beyond. With a total yearly capacity of 600,000 units and equipped with the latest technology in terms of security and surveillance, the intermodal terminal is connected by combined train shuttles to the main ports and industrial regions.
www.cfl-mm.lu

ABOUT TRAXENS
Traxens generates, collects, consolidates, enriches and transforms logistics asset data into actionable insight for its clients in the maritime, rail and supply chain industries.
The company’s breakthrough Internet-of-Big-Things technology provides comprehensive, real-time information for managing logistics assets anywhere in the world. Traxens’ solutions digitally transform multi-modal supply chains, enabling customers to reduce costs, optimize investments, comply with environmental regulations and deliver premium services to their customers. Traxens’ IoT solution received the Frost & Sullivan’s Technology Leadership Award in 2019.
www.traxens.com

Contact:

PRESS: Géraldine Saunière DIRECTOR OF COMMUNICATIONS Mail: g.sauniere@traxens.com Tel: +33 695 915 899

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release

Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye